164 related articles for article (PubMed ID: 20167172)
1. Siphon effects on continuous subcutaneous insulin infusion pump delivery performance.
Zisser HC; Bevier W; Dassau E; Jovanovic L
J Diabetes Sci Technol; 2010 Jan; 4(1):98-103. PubMed ID: 20167172
[TBL] [Abstract][Full Text] [Related]
2. Accuracy assessment of bolus and basal rate delivery of different insulin pump systems used in insulin pump therapy of children and adolescents.
Ziegler R; Waldenmaier D; Kamecke U; Mende J; Haug C; Freckmann G
Pediatr Diabetes; 2020 Jun; 21(4):649-656. PubMed ID: 32003490
[TBL] [Abstract][Full Text] [Related]
3. Insulin Pumps: Review of Technological Advancement in Diabetes Management.
Sora ND; Shashpal F; Bond EA; Jenkins AJ
Am J Med Sci; 2019 Nov; 358(5):326-331. PubMed ID: 31655714
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems.
Freckmann G; Kamecke U; Waldenmaier D; Haug C; Ziegler R
Diabetes Technol Ther; 2019 Apr; 21(4):201-208. PubMed ID: 30901232
[TBL] [Abstract][Full Text] [Related]
5. All Insulin Pumps Are Not Equivalent: A Bench Test Assessment for Several Basal Rates.
Girardot S; Jacquemier P; Mousin F; Rendekeu C; Hardy S; Riveline JP
Diabetes Technol Ther; 2020 Jun; 22(6):476-483. PubMed ID: 32069066
[No Abstract] [Full Text] [Related]
6. Comparative Dose Accuracy of Durable and Patch Insulin Pumps Under Laboratory Conditions.
Laubner K; Singler E; Straetener J; Siegmund T; Päth G; Seufert J
Diabetes Technol Ther; 2019 Jul; 21(7):371-378. PubMed ID: 31149838
[No Abstract] [Full Text] [Related]
7. Comparative dose accuracy of durable and patch insulin infusion pumps.
Jahn LG; Capurro JJ; Levy BL
J Diabetes Sci Technol; 2013 Jul; 7(4):1011-20. PubMed ID: 23911184
[TBL] [Abstract][Full Text] [Related]
8. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy.
Renard E
Curr Opin Pharmacol; 2002 Dec; 2(6):708-16. PubMed ID: 12482735
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of a new patch pump based on a microelectromechanical system (MEMS) compared to other commercially available insulin pumps: results of the first in vitro and in vivo studies.
Borot S; Franc S; Cristante J; Penfornis A; Benhamou PY; Guerci B; Hanaire H; Renard E; Reznik Y; Simon C; Charpentier G;
J Diabetes Sci Technol; 2014 Nov; 8(6):1133-41. PubMed ID: 25079676
[TBL] [Abstract][Full Text] [Related]
10. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
Jarosz-Chobot P
Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels.
Walsh J; Roberts R; Bailey T
J Diabetes Sci Technol; 2010 Sep; 4(5):1174-81. PubMed ID: 20920437
[TBL] [Abstract][Full Text] [Related]
13. Diabetes management in the new millennium using insulin pump therapy.
Bode BW; Sabbah HT; Gross TM; Fredrickson LP; Davidson PC
Diabetes Metab Res Rev; 2002; 18 Suppl 1():S14-20. PubMed ID: 11921425
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion.
Ziegler R; Oliver N; Waldenmaier D; Mende J; Haug C; Freckmann G
Diabetes Technol Ther; 2021 May; 23(5):350-357. PubMed ID: 33210949
[No Abstract] [Full Text] [Related]
15. Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial.
Aronson R; Li A; Brown RE; McGaugh S; Riddell MC
Lancet Diabetes Endocrinol; 2020 Jun; 8(6):511-523. PubMed ID: 32445738
[TBL] [Abstract][Full Text] [Related]
16. Selection for and initiation of continuous subcutaneous insulin infusion. Proceedings from a workshop.
Hanas R
Horm Res; 2002; 57 Suppl 1():101-4. PubMed ID: 11979036
[TBL] [Abstract][Full Text] [Related]
17. Continuous subcutaneous insulin infusion (CSII) pumps.
Valla V
Adv Exp Med Biol; 2012; 771():414-9. PubMed ID: 23393693
[TBL] [Abstract][Full Text] [Related]
18. Comparison of different insulin pump makes under routine care conditions in adults with Type 1 diabetes.
Leelarathna L; Roberts SA; Hindle A; Markakis K; Alam T; Chapman A; Morris J; Urwin A; Jinadev P; Rutter MK
Diabet Med; 2017 Oct; 34(10):1372-1379. PubMed ID: 28636773
[TBL] [Abstract][Full Text] [Related]
19. Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus.
Zisser HC; Bevier WC; Jovanovic L
Diabetes Technol Ther; 2007 Dec; 9(6):509-15. PubMed ID: 18034605
[TBL] [Abstract][Full Text] [Related]
20. In vitro Stability of Biosimilar Insulin Aspart SAR341402 in the Medtronic MiniMed Insulin Pumps.
Mohnicke M; Blecher A; Beichert K; Bidlingmaier B; Todt EJ; Dette C; Rotthaeuser B; Mukherjee B
J Pharm Sci; 2023 Apr; 112(4):963-973. PubMed ID: 36521561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
